Gene · 9201
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CPT1A-mediated IDO1 succinylation shapes EGFRvIII-driven resistance to tumor electric field therapy in glioblastoma. | Nat Commun | 2026 | 42806046 | PubTator, text mining | PubMed |
| Tuft cells contribute to the pathogenesis of human primary and experimental murine Sjögren's disease. | J Dent Sci | 2026 | 42688877 | PubTator, text mining | PubMed |
| SEC14L2 contributes to tumor progression by enhancing USP5-driven RBM3 deubiquitination in pancreatic ductal adenocarcinoma. | Oncogene | 2026 | 42649370 | PubTator, text mining | PubMed |
| Dietary vitamin A restricts intestinal tuft cell differentiation. | Cell Rep | 2026 | 42593965 | PubTator, text mining | PubMed |
| Immunohistochemistry-based molecular subtypes and stromal tumor-infiltrating lymphocytes in triple-negative breast cancer: a chemotherapy-only cohort. | Oncologist | 2026 | 42587422 | PubTator, text mining | PubMed |
| Cross-species functional analysis of a de novo DCLK1 variant associated with a neurodevelopmental disorder. | Res Sq | 2026 | 42539103 | PubTator, text mining | PubMed |
| Transcriptome profiling of ocular surface ectoderm derived from embryonic stem cells, and identification of CACNG6 and AQP3 as its surface markers. | Int J Ophthalmol | 2026 | 42523845 | PubTator, text mining | PubMed |
| MEK1 as a Synthetic Lethal Target with Cabozantinib in Renal Cell Carcinoma: Insights from CRISPR/Cas9 Screening. | Genes (Basel) | 2026 | 42510829 | PubTator, text mining | PubMed |
| DCLK1 regulates stemness and IL-6/STAT3-dependent metastatic niche formation in chemoresistant ovarian cancer. | J Exp Clin Cancer Res | 2026 | 42210222 | PubTator, text mining | PubMed |
| Smooth muscle cells transiently acquire a CD34+ progenitor state upon injury to drive pathological vascular remodeling. | Cell Stem Cell | 2026 | 42190659 | PubTator, text mining | PubMed |
Doublecortin-Like Kinase 1 Expression in HER2-Positive Breast Cancer: Relation to Clinicopathological Characteristics and Response to Subcutaneous Injection of Pertuzumab-Trastuzumab (Phesgo) as a Part of Neoadjuvant Chemotherapy. | Pathol Int | 2026 | 42116617 | PubTator, text mining | PubMed |
| Modeling Synaptic Maturation From Growth Cone to Synapse in Human Organoids. | J Neurochem | 2026 | 42108706 | PubTator, text mining | PubMed |
| miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer. | Int J Mol Sci | 2026 | 42074325 | PubTator, text mining | PubMed |
| An integrated single-cell transcriptomics and explainable AI approach for cancer stemness biomarker discovery in non-small cell lung cancer. | Comput Biol Chem | 2026 | 42066389 | PubTator, text mining | PubMed |
| Abstracts from The XXV Brazilian Diabetes Society Meeting. | Diabetol Metab Syndr | 2026 | 41913261 | PubTator, text mining | PubMed |
| Genetic associations of variants in 10 glaucoma-related genes with POAG risk and structural phenotypes in Korean subjects. | Medicine (Baltimore) | 2026 | 41894275 | PubTator, text mining | PubMed |
| Immunocytochemical Analysis of Stem Cell Markers in Pancreatic Adenocarcinoma. | Cytopathology | 2026 | 41873013 | PubTator, text mining | PubMed |
| Quantifying the fidelity of in vitro human cell culture systems using a biomedical foundation model. | Proc Natl Acad Sci U S A | 2026 | 41860964 | PubTator, text mining | PubMed |
| Circulating Cell Type Senescence Signatures Reveal High-Resolution Health Status and Trajectories in Human Longitudinal Studies. | medRxiv | 2026 | 41728302 | PubTator, text mining | PubMed |
| Solitary chemosensory cells amplify eosinophilic inflammation via PAR-2 activation in house dust mite-sensitized allergic rhinitis. | World Allergy Organ J | 2026 | 41717077 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9201/papers